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Acute aortic dissection (AAD) is a life-threatening cardiovascular disease caused by progressive medial degeneration of the 
aortic wall. A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAMTS1) is a recently identified extracellu-
lar metalloproteinase participating in the development of vascular disease, such as atherosclerosis. In the present study, we 
found that ADAMTS1 was significantly elevated in blood samples from AAD patients compared with patients with acute my-
ocardial infarction and healthy volunteers. Based on these findings, we established an AAD model by infusing angiotensin II in 
older mice. AAD was successfully developed in aorta tissues, with an incidence of 42% after 14 days in the angiotensin II 
group. Macrophage and neutrophil infiltration was observed in the media of the aorta, and ADAMTS1 overexpression was 
found in the aorta by Western blot and immunohistochemistry. Double immunofluorescence staining showed the expression of 
ADAMTS1 in macrophages and neutrophils. Consistent with the upregulation of ADAMTS1 in aortic dissection tissues, ver-
sican (a proteoglycan substrate of ADAMTS1) was degraded significantly more in these tissues than in control aortic tissues. 
These data suggest that the increased expression of ADAMTS1 protein in macrophages and neutrophils that infiltrated aortic 
tissues may promote the progression of AAD by degrading versican. 
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Acute aortic dissection (AAD) is a potentially fatal disease 
of the adult aorta. The incidence of AAD in the general 
population has increased over the past 10 years, becoming a 
significant burden on healthcare systems (Sampson, 2014a, 
b). Although the sudden onset of severe sharp back or chest 
pain and computed tomography images are effective for 
diagnosis, no specific biomarkers are available for the 
prompt diagnosis of AAD. Progressive medial degeneration 
of the aortic wall is known to be an important pathogenic 
factor for the development of AAD. However, the underly-
ing mechanism that links medial degeneration and the onset 
of AAD remains unclear. 
The recently identified metalloproteinase family 
ADAMTS (a disintegrin and metalloproteinase with 
thrombospondin motifs) has been implicated in the devel-
opment and progression of many cardiovascular diseases 
(Jonsson-Rylander et al., 2005; Wagsater et al., 2008; Wang 
et al., 2009; Zhang et al., 2015). The family member a dis-
60 Gao, Y., et al.   Sci China Life Sci   January (2016) Vol.59 No.1 
integrin and metalloproteinase with thrombospondin mo-
tifs-1 (ADAMTS1) is a secreted protease that participates in 
various biological processes, such as ovulation, inflamma-
tion, and angiogenesis (Iruela-Arispe et al., 2003; Ng et al., 
2006; Russell et al., 2003). ADAMTS1 functions in extra-
cellular matrix (ECM) remodeling by digesting modular 
proteoglycans, such as versican, aggrecan, and brevican 
(Kuno et al., 2000; Russell et al., 2003). Furthermore, the 
increased expression of ADAMTS1 has been implicated in 
acute vascular events, such as atherosclerotic plaque rupture 
(Jonsson- Rylander et al., 2005; Sabatine et al., 2008). 
However, little is known about the involvement of 
ADAMTS1 in the development of AAD. 
In the present study, we found that ADAMTS1 was sig-
nificantly elevated in human blood samples from AAD pa-
tients. Based on these findings, we established a mouse 
model of AAD by infusing angiotensin II (Ang II) in older 
mice. The upregulation of ADAMTS1 expression in mac-
rophages and neutrophils that infiltrated the aortic lesions 
was found in this model, which was associated with the 
increased degradation of versican. Altogether, our study 
provides the first evidence that ADAMTS1 release from 
macrophages and neutrophils might contribute to the de-
velopment of AAD. 
RESULTS 
Elevated levels of ADAMTS1 in blood samples from 
AAD patients 
We first screened the circulating levels of ADAMTS1 in 
blood samples from healthy control volunteers and patients 
with acute myocardial infarction (AMI) or AAD. No signif-
icant differences were observed in average age, the ratio of 
men to women, or the incidence of major risk factors among 
these groups (Table 1). As shown in Figure 1A, the AAD 
group exhibited significantly higher plasma levels of 
ADAMTS1 than the control or AMI group. 
Table 1  Demographic and clinical characteristics of the patients and 
controls included in the study. The data are expressed as mean±SEM or the 
number (percentage) of subjects. AMI, acute myocardial infarction; AAD, 








Age (years) 582 603 554 
Male sex, n (%) 11 (58%) 20 (77%) 13 (81%) 
Smoking, n (%) 10 (53%) 21 (81%) 9 (56%) 
Hypertension, n (%) 12 (63%) 17 (65%) 11 (69%) 
Diabetes mellitus, n (%) 4 (21%) 7 (27%) 1 (6%) 
Hyperlipidemia, n (%) 5 (26%) 11 (42%) 3 (19%) 
 
Immunolocalization of ADAMTS1 in aortic lesions in 
AAD patients 
Immunohistochemistry of the patient samples indicated that 
the AAD tissues contained abundant ADAMTS1-positive 
cells that were located mainly in the medial layer of dis-
sected aorta (Figure 1B). Mononuclear and polymorphonu-
clear inflammatory cells accumulated in much higher levels 
in dissected aorta from AAD patients (Figure 1B). Because 
the ADAMTS1 staining pattern in the AAD aorta was simi-
lar to inflammatory cells, we performed double immunoflu-
orescence staining of ADAMTS1+CD68 (macrophages) 
and ADAMTS1+neutrophil elastase (neutrophils) in AAD 
aortic tissues and found that both ADAMTS1+CD68 and 
ADAMTS1+neutrophil elastase colocalized in the cells 
(Figure 2). 
Establishment of an AAD model by Ang II infusion in 
older mice 
Based on the finding that ADAMTS1 is upregulated in hu-
man AAD, we sought to define its role in AAD in vivo by 
developing a relevant mouse model. Ang II infusion was 
previously reported to induce aortic dissection (Tieu et al., 
2009). We evaluated the effects of short-term Ang II infu- 
 
 
Figure 1  ADAMTS1 protein expression is elevated in blood and dissected aortic tissue samples from AAD patients, and dissected aortic media is infiltrat-
ed by numerous inflammatory cells. A, ADAMTS1 was assayed using an enzyme-linked immunosorbent assay for the marker in human peripheral blood 
samples from healthy volunteers (n=19), AMI patients (n=26), and AAD patients (n=16). The data are expressed as mean±SEM. ***, P<0.001. B, Aortic 
tissues were obtained from patients with AAD and subjected to histology and immunohistochemistry to detect ADAMTS1 in serial frozen sections. The 
distribution of ADAMTS1-positive cells and inflammatory cells was closely related. High magnification in the rectangular areas is shown in the lower rows 
in each panel. Black arrowheads indicate inflammatory cells. Yellow arrowheads indicate positively immunostained cells. Scale bar, 200 and 50 m (upper 
and lower panels, respectively). Med, media; FL, false lumen; H&E, hematoxylin and eosin stain. 
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Figure 2  Dissected aortic media from AAD patients is infiltrated by numerous ADAMTS1-positive neutrophils and macrophages. A, Aortic tissues ob-
tained from AAD patients were subjected to immunofluorescence staining for ADAMTS1 and neutrophil elastase (Neutrophil) on serial frozen sections. 
White arrows indicate ADAMTS1+neutrophil elastase-double-positive cells. B, Aortic tissues obtained from AAD patients were subjected to immunofluo-
rescence staining for ADAMTS1 and CD68 (macrophage) on serial frozen sections. White arrows indicate ADAMTS1+CD68-double-positive cells. Scale 
bar, 50 m.  
sion in 8- to 9-month-old C57BL/6 mice at a dose of 2,500 
ng kg1 min1. The infusion of Ang II at this dose produced 
modest pressure effects. Systolic blood pressure 7 days 
post-infusion was 154±5 mmHg vs. 106±2 mmHg pre-  
infusion (P<0.001; Figure 3A). Aortic dissection was ob-
served in 42% of the experimental mice (5 of 12) after in-
traventricular phosphate-buffered saline perfusion to re-
move lumenal blood cells (Figure 3B). Aortic dissection 
was not observed in sham-infused control mice. Further-
more, 80% of the mice suffering from aortic dissection (4 of 
5) died as a result of aortic rupture. Dissections commonly 
spanned the length of the aorta from the thoracic to supra-
renal aorta (Figure 3C). The analysis of aortic cross-sections 
in the suprarenal abdominal region clearly showed Ang 
II-induced medial hypertrophy, adventitial thickening, and 
blood-filled false lumens located in the tunica adventitia 
(Figure 3D). 
Elevated plasma ADAMTS1 levels in early stage of Ang 
II-induced AAD in older mice 
We detected the circulating levels of ADAMTS1 and C- 
reactive protein (CRP) in blood samples from control and 
Ang II-infused mice at day 3, 7 and 14 after replacement of 
the minipumps. As shown in Figure 4, the Ang II-treated 
group exhibited significantly higher plasma levels of 
ADAMTS1 and CRP than the control group at day 3 and 7. 
In addition, the plasma ADAMTS1 levels were elevated 
more significantly, and the increased plasma CRP levels 
lasted longer. No significant differences were observed in 
plasma ADAMTS1 levels between two groups at day 14 
after implantation of the minipumps. 
Immunolocalization of ADAMTS1 in aortic lesions in 
Ang II-infused mice 
Histology showed that the accumulation of inflammatory 
cells was localized to the media of the dissected aorta in 
Ang II-treated mice (Figure 3D). We performed double 
immunofluorescence staining of ADAMTS1+CD68 and 
ADAMTS1+neutrophil elastase in AAD aortic tissues and 
found that ADAMTS1+CD68 and ADAMTS1+neutrophil 
elastase colocalized in the cells (Figure 5). More important-
ly, the infiltration of ADAMTS1-positive macrophages and 
neutrophils was observed not only in the dissected media 
but also in the intima and adventitia in Ang II-induced AAD 
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Figure 3  Angiotensin II infusion in older mice induces AAD. A, Systolic blood pressure was measured in saline- and Ang II-treated older mice (n=12 per 
group). ***, P<0.001. B, Incidence of AAD in older mice infused with saline or Ang II. C, Representative excised aortas show that older mice that were 
infused with Ang II developed AAD (upper). The figure shows the histology of aortas from control and Ang II-treated mice stained with elastica Van Gieson 
(lower). Notice the aortic dissection (arrowheads, false lumen) in the Ang II-treated mouse. Scale bar, 200 m. D, Dissected aortic media from AAD mice is 
infiltrated by numerous inflammatory cells. Aortic tissues were obtained from control and Ang II-treated mice and subjected to histology using H&E. High 
magnification of the rectangular areas is shown in the right panels in each row. Black arrowheads indicate inflammatory cells. Scale bar, 200 m and 50 m 
(left and right panels, respectively). SBP, systolic blood pressure; Med, media; FL, false lumen; H&E, hematoxylin and eosin stain. 
thoracic aortas (Figure 5). In control mice, the immunoflu-
orescence staining of macrophages or neutrophils revealed 
hardly any ADAMTS1 expression in the tissues (Figure 5). 
These findings suggest that the increased levels of 
ADAMTS1 released from macrophages and neutrophils in 
AAD aortas might be involved in the development of AAD. 
Increased ADAMTS1 expression and versican degrada-
tion in aortic tissues in Ang II-infused mice 
We examined the mRNA levels of ADAMTS1, the 
ADAMTS1 inhibitor tissue inhibitor metalloproteinases 3 
(TIMP3), and the ADAMTS1 substrate versican using re-
verse-transcription PCR (RT-PCR) in mouse aortic tissues 
14 days after Ang II infusion. The elevated mRNA expres-
sion of TIMP3 and versican was observed in aortas in Ang 
II-treated mice (Figure 6A–C). Western blot showed that 
the levels of ADAMTS1 and the versican degradation 
product DPEAEE were significantly higher and the level of 
versican was significantly lower in AAD tissues than in 
control aortic tissues (Figure 6D–G). The levels of versican 
degradation products strongly correlated with the levels of 
ADAMTS1 protein, suggesting a crucial role for 
ADAMTS1 in the degradation of versican in AAD. 
DISCUSSION 
In the present study, we found that the plasma levels of 
ADAMTS1 were elevated in AAD patients but not in pa-
tients with AMI or healthy control volunteers. Furthermore, 
increased circulating levels of ADAMTS1 were correlated 
with the presence of ADAMTS1-positive macrophages and 
neutrophils accumulated in aortic tissues in AAD patients. 
Given these findings from studies of human AAD speci-
mens, we established a mouse model that develops AAD by 
Ang II infusion. Consistent with findings in AAD patients, 
plasma ADAMTS1 levels in Ang II-induced AAD mice 
were markedly elevated. Aortic tissue from AAD mice ex-
hibited enhanced expression of ADAMTS1, and 
ADAMTS1-immunoreactive macrophages and neutrophils 
infiltrated dissected intima, media, and adventitia. Moreo- 
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Figure 4  Circulating levels of ADAMTS1 and CRP are elevated in blood 
samples from Ang II-treated older mice. ADAMTS1 (A) and CRP (B) 
were assayed using enzyme-linked immunosorbent assays for the markers 
in mouse peripheral blood samples from older mice treated with vehicle 
(control) or Ang II. The data are expressed as mean±SEM. *, P<0.05, ***, 
P<0.001.  
ver, the levels of ADAMTS1 protein were strongly corre-
lated with the levels of versican degradation in dissected 
tissues. Our results suggest that ADAMTS1 may play an 
important role in the development of AAD. 
Despite the technical advances in and resources dedicat-
ed to the treatment of AAD, it is a potentially fatal vascular 
disease with high mortality. Early detection of AAD is 
clearly needed. AAD is pathologically associated with de-
generation of aortic media, which is characterized by 
smooth muscle cells loss along with the degradation of ex-
tracellular matrix (Wu et al., 2013). Conversely, AMI is 
characterized by acute cardiomyocyte necrosis due to myo-
cardial ischemia, triggering an intense inflammatory re-
sponse (Fang et al., 2015). Our results suggest that 
ADAMTS1 may contribute to the loss of structural and 
functional integrity of the aortic wall in the progression of 
AAD by the degradation of versican, an extracellular matrix 
protein. This might explain that the circulating levels of 
ADAMTS1 were elevated only in AAD but not in AMI 
patients in our study, albeit both conditions are highly in-
flammatory. ADAMTS1 may therefore serve as a biomarker 
of differential diagnosis for AAD and AMI. 
Matrix metalloproteinases are candidates in the patho-
logical molecular mechanisms of AAD (Zhang et al., 2009). 
These enzymes degrade the ECM, modulate inflammation, 
and regulate tissue remodeling. Kurihara et al. (2012) 
demonstrated that MMP9 was elevated in the pathogenesis 
of aortic dissection, and the genetic deletion or pharmaceu-
tical inhibition of MMP9 attenuated the incidence of AAD. 
Similarly, we observed that MMP9 protein expression was 
increased in aortic tissues in Ang II-treated mice in the pre-
sent study (Figure S1). 
ADAMTS is a recently identified family of extracellular 
metalloproteinases that has been shown to participate in 
tissue destruction (Kuno et al., 1997). The ADAMTS family 
of proteins comprises 20 members. ADAMTS1 is a particu-
larly well-studied member of this family. Accumulating 
evidence suggests that ADAMT1 plays an important role in 
cardiovascular disease (Ashlin et al., 2013; Jonsson- 
Rylander et al., 2005; Seidelmann et al., 2008). Jons-
son-Rylander et al. showed that ADAMTS1 promoted ath-
erogenesis by cleaving ECM proteins, such as versican, and 
promoting vascular smooth muscle cell migration (Jonsson- 
Rylander et al., 2005). Consistent with our findings, Ren et 
al. also found that ADAMTS1 and ADAMTS4 expression 
was significantly increased in the aortic wall of human tho-
racic aortic aneurysm and dissection (Ren et al., 2013). 
However, they enrolled patients with chronic aortic dissec-
tion, and the time interval since dissection onset to test was 
several years. But we enrolled patients with acute aortic 
dissection, and the blood and tissue samples from AAD 
patients were collected within hours after dissection onset. 
Furthermore, they only found ADAMTS1 expression was 
increased in the aortic wall of human thoracic aortic aneu-
rysm and dissection, but we proved that ADAMTS1 expres-
sion was similarly elevated in plasma and aortic tissues 
from patients with acute aortic dissection and Ang 
II-induced mouse models. In addition, they showed 
ADAMTS1 expression in smooth muscle cells and macro-
phages of dissected tissues, but we observed ADAMTS1 
expression in neutrophils and macrophages accumulated in 
aortic tissues, but not in smooth muscle cells. Although 
there were many differences in detail between the findings 
in the present study versus those reported by Ren et al, these 
two studies suggest that ADAMTS1 played an important 
role in the different stages of aortic dissection. 
We believe that ADAMTS1-knockout or knockdown 
animals may better reveal the role of ADAMTS1 in the 
pathogenesis of aortic dissection. If the occurrence of aortic 
dissection is inhibited in ADAMTS1-knockout or knock-
down mice infused with Ang II, it would greatly strengthen 
our suppositions that ADAMTS1 might promote the devel-
opment of aortic dissection. However, the targeted disrup-
tion of the ADAMTS1 gene resulted in ovarian defects as-
sociated with severely impaired fertility (Boerboom et al., 
2003). In addition, it was senseless to inhibit ADAMTS1 
expression in vivo in our study by tail-vein injection of spe-
cific siRNA adenovirus, since the elevated expression of 
ADAMTS1 mainly located in macrophages and neutrophils 
of dissected tissue, and leucocytes cannot be infected with 
adenovirus due to lack of adenovirus-specific receptors. At 
present, we could not get a sufficient number of 
ADAMTS1-knockout or knockdown mice to demonstrate   
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Figure 5  Dissected aortic media from AAD mice were infiltrated by numerous ADAMTS1-positive neutrophils and macrophages. A, Aortic tissues were 
obtained from the control and Ang II-treated mice and subjected to immunofluorescence staining for ADAMTS1 and neutrophil elastase (Neutrophil) on 
serial frozen sections. White arrows indicate ADAMTS1+neutrophil elastase-double-positive cells. B, Aortic tissues were obtained from the control and Ang 
II-treated mice and subjected to immunofluorescence staining for ADAMTS1 and CD68 (macrophage) on serial frozen sections. White arrows indicate 
ADAMTS1+CD68-double-positive cells. Scale bar, 50 m. 
that the increased expression of ADAMTS1 was required 
for the development of aortic dissection. 
Versican is a major proteoglycan component of the vas-
cular wall. It is mainly expressed in smooth muscle cells 
and can be cleaved by various enzymes, including 
ADAMTS1 (Jonsson-Rylander et al., 2005). Versican exists 
in at least four different isoforms, including V0, V1, V2, and 
V3, which are created by the alternative splicing of mRNA 
from a single gene (Wight and Merrilees, 2004). Although 
studies suggest that versican may be involved in vascular 
smooth muscle cell migration, proliferation, and low-  
density lipoprotein oxidation processes, such as retention, 
and participate in the development of atherosclerosis and 
other vascular diseases. The role of versican in vascular 
physiology and pathophysiology has not yet been clarified. 
A genetic analysis of familial thoracic aortic aneurysms and 
aortic dissection patients found that chromosome 5q13-14 is 
a highly pathogenic site for the disease (Guo et al., 2001), 
and the versican gene is located at this locus. The concen-
tration of versican in the arterial wall was 89% lower in 
patients with aneurysms (Theocharis et al., 2001). Further 
research found a significant increase in the versican degra-
dation fragment in the vascular wall in aortic aneurysm tis-
sues (Theocharis et al., 2003). These studies suggest that 
versican degradation may be associated with the progres-
sion of aortic dissection or aneurysm. In the present study, 
we found that versican degradation increased in aortic tis-
sues in Ang II-treated mice, accompanied by an increase in 
ADAMTS1 protein expression. The increased mRNA levels 
of versican and TIMP3 might reflect feedback changes as-
sociated with versican degradation and elevated ADAMTS1 
expression. This strong correlation suggests that the eleva-
tion of ADAMTS1 protein levels may be responsible for the 
increase in versican degradation. 
In summary, ADAMTS1 levels were elevated in patients 
with AAD and may contribute to the progression of AAD. 
ADAMTS1 could serve as a potential biomarker for AAD 
and possible therapeutic target for the treatment of AAD. 
MATERIALS AND METHODS 
Human blood and affected aortic samples 
Between January 2011 and December 2013, 16 patients  
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Figure 6  Acute aortic dissection in Ang II-treated older mice is accompanied by enhanced ADAMTS1 expression and versican degradation. Analysis of 
ADAMTS1 (A), TIMP3 (B), and versican (C) mRNA expression by real-time polymerase chain reaction in aortic tissues from older mice treated with vehi-
cle (control) or Ang II. Polymerase chain reaction products from three independent samples from each group are shown. D, Representative Western blots of 
ADAMTS1, versican, and the degradation product of versican (DPEAEE) in aortic tissues from older mice treated with vehicle (control) or Ang II. Analysis 
of ADAMTS1 (E), versican (F), and DPEAEE (G) protein expression by Western blot. The data are expressed as mean±SEM. *, P<0.05; **, P<0.01. TIMP3, 
tissue inhibitor of metalloproteinases3. 
who were diagnosed with AAD, 26 patients with AMI, and 
19 healthy volunteers were enrolled in the study. All of the 
AAD patients were free from connective tissue disorders, 
such as Marfan syndrome, Ehlers-Danlos syndrome, and 
aortitis diagnosed according to clinical history and physical 
examination. The blood samples from AAD and AMI pa-
tients were collected within 1 h after arrival in the hospital’s 
emergency room. AAD and AMI patients who arrived at the 
hospital 10 h after the onset of clinical symptoms were ex-
cluded from the study. The diagnosis of AAD and AMI was 
confirmed by computed tomography and electrocardiogram, 
respectively. The concentrations of ADAMTS1 in blood 
samples were analyzed using a human ADAMTS1 en-
zyme-linked immunosorbent assay (ELISA) kit (MyBio-
Soure, San Diego, CA, USA). Affected aortic specimens 
were obtained at surgery from 25 AAD patients, who un-
derwent surgery for aortic grafts. The human samples were 
collected in the China-Japan Friendship Hospital, and writ-
ten informed consent for the usage of the samples for the 
experiments was obtained from all of the subjects. The 
study was approved by the ethics committee of China-Japan 
Friendship Hospital. 
Animal care and use 
Eight- to nine-month-old male C57BL/6 mice were pur-
chased from the Animal Center of Peking University Health 
Science Center (Beijing, China) and maintained in a specif-
ic pathogen-free facility at the Experimental Center of China-  
Japan Friendship Hospital (accredited for animal care by the 
Chinese Association for Accreditation of Laboratory Ani-
mal Care) under a 12 h/12 h light/dark cycle with controlled 
room temperature and free access to standard chow and tap 
water. Two groups of mice (n=12 per group) received con-
tinuous Ang II (2,500 ng kg1 min1; Sigma Chemical, St. 
Louis, MO, USA) or saline via subcutaneous osmotic min-
ipumps (Alza, Palo Alto, CA, USA) for 14 days. We take 
the blood of mice at day 3, 7 and 14 after implantation of 
the minipumps. The concentrations of ADAMTS1 and CRP 
in blood samples were analyzed using a mouse ADAMTS1 
ELISA kit (MyBioSoure, San Diego, CA, USA) and a 
mouse C-reactive protein ELISA kit (ADI, San Antonio, 
TX, USA). 
Blood pressure measurement 
Arterial systolic blood pressure (SBP) and heart rate (HR) 
were measured in conscious, restrained mice using a nonin-
vasive computerized tail-cuff system (Muromachi Kikai, 
Tokyo, Japan). Measurements were performed every day, 
beginning 2 days before placement of the minipumps. The 
blood pressure value for each mouse was calculated as the 
average of three separate measurements in each session. 
Histology and immunohistochemistry 
Paraformaldehyde-fixed tissue was embedded with opti-
mum cutting temperature compound or paraffin and pro-
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cessed, and 6 m sections were stained with hematoxy-
lin-eosin or elastica Van Gieson. Additional sections were 
immunostained using an indirect horseradish peroxidase 
immunoperoxidase method and specific antibody for the 
antigen of ADAMTS1 (Abcam, Cambridge, MA, USA). 
Negative controls for the immunostaining consisted of re-
placing each of the primary antibodies with an equivalent 
concentration of irrelevant rabbit polyclonal antibody. At 
least three different specimens were analyzed. 
Immunofluorescence staining 
For the dual immunofluorescence assay, frozen sections 
were incubated with anti-ADAMTS1 (Abcam, Cambridge, 
MA, USA), anti-CD68, or anti-neutrophil elastase (Santa 
Cruz, CA, USA) primary antibody and then Alexa Fluor 
488 donkey anti-rabbit immunoglobulin G (IgG) or Alexa 
Fluor 555 donkey anti-goat IgG (Invitrogen, Carlsbad, CA, 
USA) secondary antibody. Nuclei were counterstained with 
4′,6-diamidino-2-phenylindole. Negative controls replaced 
primary antibody with IgG. The fluorescence signal was 
monitored by confocal laser scanning microscopy (Leica, 
Wetzlar, Germany). 
Quantitative real-time RT-PCR 
Total RNA from mouse aortas was isolated using Trizol 
reagent (Applygen Technologies, Beijing, China) and re-
verse-transcribed with a reverse transcription system 
(Promega, Madison, WI, USA). The reaction mixture then 
underwent polymerase chain reaction (PCR). The amount of 
PCR products formed in each cycle was evaluated by SYBR 
Green I fluorescence. Amplification reactions were per-
formed using the ABI Prism 7500 PCR System. All of the 
amplification reactions underwent 35 cycles and were per-
formed in duplicate (an initial stage of 5 min at 95C, fol-
lowed by a three-step cycle of 30 s at 95C, 30 s at 60C, 
and 30 s at 72C). The accuracy of the PCR products was 
confirmed by sequencing the amplicons. The relative target 
mRNA levels were normalized to the internal control, 
β-actin. The following primers were used: ADAMTS1 
(forward, TTTGGCCAGCAGCTACATCT; reverse, CAC- 
ACCTTCACAGAGGCTGA), TIMP3 (forward, CACGGA- 
AGCCTCTGAAAGTC; reverse, AATTGCAACCCAGGT- 
GGTAG), versican (forward, CAAGCCAAAATGGAAA- 
CCAG; reverse, CCCCTTGTAGTCCTGACCAA), β-actin 
(forward, ATCTGGCACCACACCTTC; reverse, AGCCA- 
GGTCCAGACGCA). 
Western blot 
The extracts of mouse tissue were collected using tissue 
lysis buffer (Beyotime, Jiangsu, China) plus 1 mmol L1 
phenylmethylsulfonyl fluoride. Total protein was quantified 
using a bicinchoninic acid protein assay (Pierce, Rockford, 
IL, USA). Proteins were separated by 10% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis and electropho-
retically transferred to nitrocellulose membranes, which 
were incubated with specific antibodies for the antigens of 
β-actin (MBL, Nagoya, Japan), ADAMTS1 (Abcam, Cam-
bridge, MA, USA), versican (Millipore, Temecula, CA, 
USA), and DPEAEE (LifeSpan BioSciences, Seattle, WA, 
USA), washed, and incubated with an appropriate 
IRDye800-conjugated second antibody (Rockland, Gil-
bertsville, PA, USA). Specific immunofluorescence bands 
were detected using the Odyssey infrared imaging system 
(LI-COR Biosciences, Lincoln, NE, USA). 
Statistical analysis 
All of the results are expressed as the mean±SEM or origi-
nal data that represented one of at least three independent 
experiments. The data were analyzed using an unpaired 
Student’s t-test and two-way analysis of variance with 
Prism software (GraphPad, La Jolla, CA, USA) followed by 
the Student-Newman-Keuls post hoc test. P<0.05 was con-
sidered statistically significant. 
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